Use of Hydroxyurea and Magnesium Pidolate for Treatment of Sickle Cell Disease
NCT00143572
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
16
Enrollment
OTHER
Sponsor class
Conditions
Anemia, Sickle Cell
Interventions
DRUG:
Magnesium Pidolate, Hydroxyurea
Sponsor
St. Jude Children's Research Hospital